Involvement of RhoA-mediated Ca(2+ )sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice

por Chiba, Yoshihiko, Ueno, Ayako, Shinozaki, Koji, Takeyama, Hisao, Nakazawa, Shuji, Sakai, Hiroyasu, Misawa, Miwa
Publicado 2005

MON-477 Octreotide and ONO-ST-468, a Novel and Potent Somatostatin Receptor Type-2 (SST2) Agonist, Suppress GH Hypersecretion in the Monkey

por Tanaka, Hirotaka, Komagata, Tatsuya, Nishio, Takuya, Ishida, Akiharu, Okada, Hiroki, Katsumata, Seishi, Shinozaki, Koji
Publicado 2019

MON-464 Non-Clinical Profiling of ONO-5788, a Novel Oral Small Molecule Somatostatin Receptor Type-2 (SST2) Agonist, to Support Studies in Humans

por Komagata, Tatsuya, Tanaka, Hirotaka, Ishida, Akiharu, Sawada, Takeshi, Neki, Shinichi, Iida, Hiroyuki, Okada, Hiroki, Katsumata, Seishi, Shinozaki, Koji
Publicado 2019

MON-459 ONO-5788, a Novel Oral Small Molecule Somatostatin Receptor Type-2 (SST2) Agonist, Attenuates GH Hypersecretion in Human GH-Secreting, Pituitary Adenoma-Derived Cells

por Zhou, Cuiqi, Bonert, Vivien, Mamelak, Adam, Kelly, Daniel, Barkhoudarian, Garni, Hoon, Dave, Komagata, Tatsuya, Shinozaki, Koji, Melmed, Shlomo
Publicado 2019

PMON170 Treating human primary non-functioning pituitary adenoma cells with cabergoline

por Begalli, Federica, Botta, Joaquin, Collier, David, Dorward, Neil, Grieve, Joan, Khan, Danyal, Kolias, Angelos, Komagata, Tatsuya, Korbonits, Mãrta, Magid, Kesson, Marcus, Hani J, McCormick, Peter J, Mendoza, Nigel, Nair, Ramesh, Rice, Thomas, Shinozaki, Koji, Suleyman, Oniz
Publicado 2022